Drooling

Devyani Lal, Andrew J. Hotaling

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Drooling is the involuntary spillage of saliva from the mouth. It is a major morbidity associated with cerebral palsy and other neurodegenerative disorders. The consequences of drooling are not restricted to medical issues but can cause major social handicaps. Severe psycho-social consequences, such as social stigmatization and emotional devastation for the patients and their families, may result. This paper reviews recent developments in the management of drooling. RECENT FINDINGS: Recent publications report encouraging results with botulinum toxin A. Several surgeons report on their long-term results. Reviews analyze anticholinergic drugs, surgical options, biofeedback, behavioral and speech therapy, and a multidisciplinary team approach. SUMMARY: A team approach is the key to successful rehabilitation. Oromotor therapy is the most useful nonsurgical option. Drugs are unsuitable for long-term use due to adverse effects causing serious medical complications or noncompliance. Botulinum toxin A injection is promising, but no data exists on optimal dosage, duration of action and frequency of repeat injections. Bilateral submandibular duct relocation with bilateral sublingual gland excision has been shown to be effective and safe in long-term follow-up of the largest series of patients. At present, it is the best available surgical option.

Original languageEnglish (US)
Pages (from-to)381-386
Number of pages6
JournalCurrent Opinion in Otolaryngology and Head and Neck Surgery
Volume14
Issue number6
DOIs
StatePublished - Dec 2006
Externally publishedYes

Fingerprint

Sialorrhea
Type A Botulinum Toxins
Sublingual Gland
Speech Therapy
Stereotyping
Injections
Cholinergic Antagonists
Cerebral Palsy
Saliva
Neurodegenerative Diseases
Pharmaceutical Preparations
Mouth
Rehabilitation
Morbidity
Therapeutics

Keywords

  • Drooling
  • Excessive salivation
  • Sialorrhea

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Surgery

Cite this

Drooling. / Lal, Devyani; Hotaling, Andrew J.

In: Current Opinion in Otolaryngology and Head and Neck Surgery, Vol. 14, No. 6, 12.2006, p. 381-386.

Research output: Contribution to journalArticle

Lal, Devyani ; Hotaling, Andrew J. / Drooling. In: Current Opinion in Otolaryngology and Head and Neck Surgery. 2006 ; Vol. 14, No. 6. pp. 381-386.
@article{a828eed5846c4e91ba4ada9c72455e7e,
title = "Drooling",
abstract = "PURPOSE OF REVIEW: Drooling is the involuntary spillage of saliva from the mouth. It is a major morbidity associated with cerebral palsy and other neurodegenerative disorders. The consequences of drooling are not restricted to medical issues but can cause major social handicaps. Severe psycho-social consequences, such as social stigmatization and emotional devastation for the patients and their families, may result. This paper reviews recent developments in the management of drooling. RECENT FINDINGS: Recent publications report encouraging results with botulinum toxin A. Several surgeons report on their long-term results. Reviews analyze anticholinergic drugs, surgical options, biofeedback, behavioral and speech therapy, and a multidisciplinary team approach. SUMMARY: A team approach is the key to successful rehabilitation. Oromotor therapy is the most useful nonsurgical option. Drugs are unsuitable for long-term use due to adverse effects causing serious medical complications or noncompliance. Botulinum toxin A injection is promising, but no data exists on optimal dosage, duration of action and frequency of repeat injections. Bilateral submandibular duct relocation with bilateral sublingual gland excision has been shown to be effective and safe in long-term follow-up of the largest series of patients. At present, it is the best available surgical option.",
keywords = "Drooling, Excessive salivation, Sialorrhea",
author = "Devyani Lal and Hotaling, {Andrew J.}",
year = "2006",
month = "12",
doi = "10.1097/MOO.0b013e328011014a",
language = "English (US)",
volume = "14",
pages = "381--386",
journal = "Current Opinion in Otolaryngology and Head and Neck Surgery",
issn = "1068-9508",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Drooling

AU - Lal, Devyani

AU - Hotaling, Andrew J.

PY - 2006/12

Y1 - 2006/12

N2 - PURPOSE OF REVIEW: Drooling is the involuntary spillage of saliva from the mouth. It is a major morbidity associated with cerebral palsy and other neurodegenerative disorders. The consequences of drooling are not restricted to medical issues but can cause major social handicaps. Severe psycho-social consequences, such as social stigmatization and emotional devastation for the patients and their families, may result. This paper reviews recent developments in the management of drooling. RECENT FINDINGS: Recent publications report encouraging results with botulinum toxin A. Several surgeons report on their long-term results. Reviews analyze anticholinergic drugs, surgical options, biofeedback, behavioral and speech therapy, and a multidisciplinary team approach. SUMMARY: A team approach is the key to successful rehabilitation. Oromotor therapy is the most useful nonsurgical option. Drugs are unsuitable for long-term use due to adverse effects causing serious medical complications or noncompliance. Botulinum toxin A injection is promising, but no data exists on optimal dosage, duration of action and frequency of repeat injections. Bilateral submandibular duct relocation with bilateral sublingual gland excision has been shown to be effective and safe in long-term follow-up of the largest series of patients. At present, it is the best available surgical option.

AB - PURPOSE OF REVIEW: Drooling is the involuntary spillage of saliva from the mouth. It is a major morbidity associated with cerebral palsy and other neurodegenerative disorders. The consequences of drooling are not restricted to medical issues but can cause major social handicaps. Severe psycho-social consequences, such as social stigmatization and emotional devastation for the patients and their families, may result. This paper reviews recent developments in the management of drooling. RECENT FINDINGS: Recent publications report encouraging results with botulinum toxin A. Several surgeons report on their long-term results. Reviews analyze anticholinergic drugs, surgical options, biofeedback, behavioral and speech therapy, and a multidisciplinary team approach. SUMMARY: A team approach is the key to successful rehabilitation. Oromotor therapy is the most useful nonsurgical option. Drugs are unsuitable for long-term use due to adverse effects causing serious medical complications or noncompliance. Botulinum toxin A injection is promising, but no data exists on optimal dosage, duration of action and frequency of repeat injections. Bilateral submandibular duct relocation with bilateral sublingual gland excision has been shown to be effective and safe in long-term follow-up of the largest series of patients. At present, it is the best available surgical option.

KW - Drooling

KW - Excessive salivation

KW - Sialorrhea

UR - http://www.scopus.com/inward/record.url?scp=33750947184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750947184&partnerID=8YFLogxK

U2 - 10.1097/MOO.0b013e328011014a

DO - 10.1097/MOO.0b013e328011014a

M3 - Article

VL - 14

SP - 381

EP - 386

JO - Current Opinion in Otolaryngology and Head and Neck Surgery

JF - Current Opinion in Otolaryngology and Head and Neck Surgery

SN - 1068-9508

IS - 6

ER -